Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 35
Early research (Phase 1)Ended earlyNCT04037865
What this trial is testing

A Renal Impairment Study for PF-06651600

Who this might be right for
Renal Impairment
Pfizer 8
Early research (Phase 1)Ended earlyNCT00721422
What this trial is testing

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Who this might be right for
Renal InsufficiencyPharmacokinetics
Pfizer 16
Early research (Phase 1)Study completedNCT04699877
What this trial is testing

Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function

Who this might be right for
Renal ImpairedGilteritinibNormal Renal Function+1 more
Astellas Pharma Global Development, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Early research (Phase 1)Study completedNCT06693765
What this trial is testing

Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

Who this might be right for
Renal ImpairmentEnd-stage Kidney DiseaseHealthy Participants
AstraZeneca 41
Early research (Phase 1)Study completedNCT05004311
What this trial is testing

The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics

Who this might be right for
HealthyRenal Impairment
Viatris Innovation GmbH 16
Early research (Phase 1)Study completedNCT02653014
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
KBP Biosciences 26
Not applicableStudy completedNCT07103421
What this trial is testing

Impact of Non Surgical Periodontal Therapy on Cystatin C Levels

Who this might be right for
Periodontitis, Chronic Kidney Disease
Latakia University 30
Early research (Phase 1)Study completedNCT03310463
What this trial is testing

Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects

Who this might be right for
Acinetobacter Baumannii Infection
Entasis Therapeutics 34
Early research (Phase 1)Study completedNCT02807077
What this trial is testing

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 40
Not applicableStudy completedNCT05208788
What this trial is testing

Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)

Who this might be right for
Renal TransplantationChronic Kidney InsufficiencyHealthy Controls
University Hospital Tuebingen 186
Early research (Phase 1)WithdrawnNCT01468259
What this trial is testing

A Multi-Center, Open-Label Study

Who this might be right for
Renal DiseaseEnd Stage Renal Disease
Chelsea Therapeutics
Early research (Phase 1)Study completedNCT02313103
What this trial is testing

Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects

Who this might be right for
Renally Impaired Subjects
USWM, LLC (dba US WorldMeds) 16
Not applicableUnknownNCT02076256
What this trial is testing

The Influence of Helping Relationships From Significant Others on Healthy Lifestyle and Quality of Life Among Patients With Chronic Kidney Disease: A Longitudinal Study

Who this might be right for
Chronic Kidney Diseases
National Cheng Kung University 250
Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Study completedNCT03506854
What this trial is testing

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

Who this might be right for
Renal Impairment
Akcea Therapeutics 16
Early research (Phase 1)Study completedNCT07012005
What this trial is testing

Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

Who this might be right for
Renal Impairment
Shionogi 14
Early research (Phase 1)Study completedNCT04935294
What this trial is testing

Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction

Who this might be right for
HealthyRenal Dysfunction
Alexion Pharmaceuticals, Inc. 16
Not applicableStudy completedNCT02085837
What this trial is testing

Healthy Transitions in Late Stage Kidney Disease

Who this might be right for
Chronic Kidney Disease
Northwell Health 130
Next Page